WELLS FARGO & COMPANY/MN - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 90 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2023$44,730
-49.0%
26,006
-42.2%
0.00%
Q2 2023$87,744
+161.5%
44,997
+272.8%
0.00%
Q1 2023$33,552
-19.4%
12,069
+0.1%
0.00%
Q4 2022$41,611
+34.2%
12,061
+0.6%
0.00%
Q3 2022$31,000
+6.9%
11,986
+0.3%
0.00%
Q2 2022$29,000
-91.2%
11,945
-85.1%
0.00%
Q1 2022$331,000
-80.3%
80,242
-38.6%
0.00%
Q4 2021$1,681,000
-29.0%
130,695
-40.3%
0.00%
-100.0%
Q3 2021$2,366,000
+792.8%
219,056
+654.9%
0.00%
Q2 2021$265,000
-22.3%
29,017
-19.8%
0.00%
Q1 2021$341,000
+162.3%
36,184
+9.5%
0.00%
Q4 2020$130,000
+170.8%
33,042
+83.7%
0.00%
Q3 2020$48,000
-69.6%
17,989
-24.5%
0.00%
Q2 2020$158,0000.0%23,833
-12.4%
0.00%
Q1 2020$158,000
-25.8%
27,207
+14.5%
0.00%
Q4 2019$213,000
-39.8%
23,752
-42.0%
0.00%
Q3 2019$354,000
-6.6%
40,939
+20.5%
0.00%
Q2 2019$379,000
+290.7%
33,971
+366.9%
0.00%
Q1 2019$97,000
-76.7%
7,276
-72.9%
0.00%
Q4 2018$416,000
-28.0%
26,871
-33.8%
0.00%
Q3 2018$578,00040,5950.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,561,150$6,125,1783.26%
Redmile Group, LLC 8,509,126$14,635,6970.70%
Avidity Partners Management LP 2,733,800$4,702,1360.19%
Frazier Life Sciences Management, L.P. 1,430,878$2,461,1100.16%
Artia Global Partners LP 95,170$163,6920.07%
Worth Venture Partners, LLC 43,772$75,2880.04%
SkyOak Wealth, LLC 60,875$104,7050.03%
Point72 Asset Management, L.P. 5,924,867$10,190,7710.03%
CORNERCAP INVESTMENT COUNSEL INC 76,811$132,1150.02%
Houlihan Financial Resource Group, Ltd. 20,000$380.02%
View complete list of GRITSTONE ONCOLOGY INC shareholders